CoorsTek Medical Announces the First Human Implantation of a New, State-of-the-Art Sacroiliac Fusion System

My Subscriptions

Payment Confirmation

Transaction Failed

Your transaction failed, please try again or contact site support.

CoorsTek Medical announced the first human implantation of a new generation of MIS Sacroiliac fusion implants performed at Mayo Clinic.  The device was developed in collaboration with Mayo Clinic to address dysfunction of the sacroiliac (SI) joint and was cleared by the FDA for use in the United States in December 2016.

The Integrity-SI™ Fusion system is a cutting-edge, third-generation SI Fusion system that improves upon previous technologies on the market by embracing the true principles of arthrodesis. These principles include aggressive and thorough joint preparation, enhanced compression, and stability via the implant’s unique and proprietary instrumentation. The implants of the Integrity-SI™ Fusion system are highly-optimized for the SI joint, and their design was based on CT studies of the sacroiliac joint and are designed for maximal compression, pull-out strength, and stability. The Integrity-SI™ Fusion system also utilizes proprietary BladeX™ MIS decortication technology that employs a rigid, deployable cutter that aggressively prepares the joint surface through a cannula and creates an optimum space using single-use, disposable blades in which maximal bone graft is delivered. The system uses a single incision to insert the FDA-approved single implant, or a primary implant and a secondary implant for rotation stability, if desired by the surgeon in some situations. The implants are approved for use with or without HA coating.

Dr. William “Woodie” Cross, one of the key developing surgeons, commented on the system, “Aggressive joint preparation is the hallmark of arthrodesis within the field of orthopedic surgery. Fusion of the SI joint is no different and surgeons should follow the simple principles we all learned in training.”

Editor’s Note:  Mayo Clinic and Dr. William Cross have a financial interest in the technology. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.